About
Heart attack treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
2,546
By Phase
EARLY_PHASE1: 1PHASE3: 1PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06652243Collaborator
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
EARLY_PHASE1Recruiting
12 participants
Started: Nov 18, 2024 · Completed: Oct 31, 2027
NCT04825743Lead Sponsor
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
PHASE3Active, not recruiting
2,463 participants
Started: Apr 24, 2021 · Completed: May 13, 2026
NCT04284995Lead Sponsor
A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
PHASE2Completed
27 participants
Started: Jun 2, 2020 · Completed: Dec 14, 2020
NCT03844191Lead Sponsor
A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4
PHASE1Completed
44 participants
Started: Feb 18, 2019 · Completed: Dec 1, 2019
Locations (1)
Headquarters
Del Mar, CA, United States
Map
Loading map...